We next wanted to see whether combining these inhibitors of the NF-κB/mTOR, hedgehog and PLK1 with topotecan resulted in a corresponding declines in expression/activation of the respective pathways/molecules in neuroblastoma cells. The gene discussed is NFKB1; the disease is neuroblastoma.